These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 33815694)

  • 1. Professional killers: The role of extracellular vesicles in the reciprocal interactions between natural killer, CD8+ cytotoxic T-cells and tumour cells.
    Del Vecchio F; Martinez-Rodriguez V; Schukking M; Cocks A; Broseghini E; Fabbri M
    J Extracell Vesicles; 2021 Apr; 10(6):e12075. PubMed ID: 33815694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural Killer Cell-Derived Vesicular miRNAs: A New Anticancer Approach?
    Fabbri M
    Cancer Res; 2020 Jan; 80(1):17-22. PubMed ID: 31672842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Killer Cell-Derived Extracellular Vesicles as a Promising Immunotherapeutic Strategy for Cancer: A Systematic Review.
    Chan AML; Cheah JM; Lokanathan Y; Ng MH; Law JX
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer extracellular vesicles as novel regulators of NK cell response.
    Soriani A; Vulpis E; Cuollo L; Santoni A; Zingoni A
    Cytokine Growth Factor Rev; 2020 Feb; 51():19-26. PubMed ID: 31837917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of antitumor potency of extracellular vesicles derived from natural killer cells by IL-15 priming.
    Zhu L; Kalimuthu S; Oh JM; Gangadaran P; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Biomaterials; 2019 Jan; 190-191():38-50. PubMed ID: 30391801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteome Analysis of Human Natural Killer Cell Derived Extracellular Vesicles for Identification of Anticancer Effectors.
    Choi JW; Lim S; Kang JH; Hwang SH; Hwang KC; Kim SW; Lee S
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33182448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural Killer Cell-Derived Extracellular Vesicles: Novel Players in Cancer Immunotherapy.
    Wu F; Xie M; Hun M; She Z; Li C; Luo S; Chen X; Wan W; Wen C; Tian J
    Front Immunol; 2021; 12():658698. PubMed ID: 34093547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-derived extracellular vesicles: friend and foe of tumour immunosurveillance.
    Dörsam B; Reiners KS; von Strandmann EP
    Philos Trans R Soc Lond B Biol Sci; 2018 Jan; 373(1737):. PubMed ID: 29158311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer.
    Bödder J; Zahan T; van Slooten R; Schreibelt G; de Vries IJM; Flórez-Grau G
    Front Immunol; 2020; 11():631713. PubMed ID: 33679726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular Vesicles from
    Luo ZW; Xia K; Liu YW; Liu JH; Rao SS; Hu XK; Chen CY; Xu R; Wang ZX; Xie H
    Int J Nanomedicine; 2021; 16():2949-2963. PubMed ID: 33907401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8
    Yu Z; Liu W; He Y; Sun M; Yu J; Jiao X; Han Q; Tang H; Zhang B; Xian Y; Qi J; Gong J; Xin W; Shi G; Shan F; Zhang R; Li J; Wei M
    J Hematol Oncol; 2021 Apr; 14(1):71. PubMed ID: 33910591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving function of cytotoxic T-lymphocytes by transforming growth factor-β inhibitor in oral squamous cell carcinoma.
    Kondo Y; Suzuki S; Takahara T; Ono S; Goto M; Miyabe S; Sugita Y; Ogawa T; Ito H; Satou A; Tsuzuki T; Yoshikawa K; Ueda R; Nagao T
    Cancer Sci; 2021 Oct; 112(10):4037-4049. PubMed ID: 34309966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A calcium optimum for cytotoxic T lymphocyte and natural killer cell cytotoxicity.
    Zhou X; Friedmann KS; Lyrmann H; Zhou Y; Schoppmeyer R; Knörck A; Mang S; Hoxha C; Angenendt A; Backes CS; Mangerich C; Zhao R; Cappello S; Schwär G; Hässig C; Neef M; Bufe B; Zufall F; Kruse K; Niemeyer BA; Lis A; Qu B; Kummerow C; Schwarz EC; Hoth M
    J Physiol; 2018 Jul; 596(14):2681-2698. PubMed ID: 29368348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicle-mediated communication between CD8
    Huang Z; Liu X; Guo Q; Zhou Y; Shi L; Cai Q; Tang S; Ouyang Q; Zheng J
    Front Immunol; 2024; 15():1376962. PubMed ID: 38562940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine leakage from perforin-burst extracellular vesicles inhibits perforin secretion by cytotoxic T-lymphocytes.
    Tadokoro H; Hirayama A; Kudo R; Hasebe M; Yoshioka Y; Matsuzaki J; Yamamoto Y; Sugimoto M; Soga T; Ochiya T
    PLoS One; 2020; 15(4):e0231430. PubMed ID: 32275689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk Neuroblastoma.
    Tang XX; Shimada H; Ikegaki N
    Front Immunol; 2021; 12():650427. PubMed ID: 33968044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of murine tumour growth through CD8
    Kogo H; Shimizu M; Negishi Y; Uchida E; Takahashi H
    Immunology; 2017 Jul; 151(3):324-339. PubMed ID: 28294313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicles reshape the tumor microenvironment to improve cancer immunotherapy: Current knowledge and future prospects.
    Hang Y; Huang J; Ding M; Shen Y; Zhou Y; Cai W
    Int Immunopharmacol; 2024 Oct; 140():112820. PubMed ID: 39096874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel 3D heterotypic spheroid model for studying extracellular vesicle-mediated tumour and immune cell communication.
    Sadovska L; Zandberga E; Sagini K; Jēkabsons K; Riekstiņa U; Kalniņa Z; Llorente A; Linē A
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1930-1935. PubMed ID: 29248729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.